Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Osteonecrosis of the Jaw

Osteonecrosis of the Jaw

en English

Complete this module today and earn yourself 1 CME Point.

Proceed to module  Shortlist  Rate Module  Share

en English


This module has been developed to educate oncology professionals in managing osteonecrosis of the jaw a side effect associated with a number of bone-targeting agents approved for use in cancer patients with bone metastases.

This module was published on 8th September, 2017.


Target Audience

This module is designed to support the clinical practise of Oncologists, Dentists and Oral Surgeons, to aid them in developing an effective management strategy for Osteonecrosis of the Jaw.

Learning Objectives

By the end of this module you should be able to:

  • Describe measures to prevent ONJ in cancer patients
  • Describe the main risk factors for ONJ development
  • Learn when to suspect and how to arrive at an early diagnosis of ONJ
  • Describe what is the most appropriate management of ONJ in each patient
  • Learn how to effectively collaborate with the dentist for the successful BTA treatment of your cancer patients.

This module awards the learner 1 CME point upon successful completion and passing of the assessment.

IT Requirements

This module requires the learner to have a good, stable internet connection and runs best on INTERNET EXPLORER 7 AND ABOVE, and MOZILLA FIREFOX on either Windows or MacOS. FLASH ADD ON is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.
If you are experiencing technical difficulties, please contact info@ecancer.org and we will get back to you as soon as possible.

Commercial Support

Production of this module was funded by an unrestricted grant from Amgen.

Disclosure Policy

ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Amgen.

Proceed to Module

Relevant to the following professions

  • Oncologist
  • Other
Proceed to module  Shortlist  Rate Module

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation